COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Why Coya Therapeutics Is A Smart Speculative Buy For Neurodegenerative Diseases [Seeking Alpha]
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium [Yahoo! Finance]
Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
Form DEFA14A Coya Therapeutics, Inc.
Form ARS Coya Therapeutics, Inc. For: Dec 31
Form DEFA14A Coya Therapeutics, Inc.
Form DEF 14A Coya Therapeutics, Inc. For: May 08
Form 10-K Coya Therapeutics, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.